{"SPADE_UN_11716": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11716", "Peptide Name": "[E]4[W]9-VmCT1-NH2 VmCT1 petide derivative", "Source": "Synthetic construct", "Family": "Belongs to the scorpion NDBP 12 family", "Gene": "Not found", "Sequence": "FLGELWNVWKSVF", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "[Ref.27912176] Gram-negative bacteria:Escherichia coli (SBS 363)(MIC=12.5μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=3.12μmol/L);Escherichia coli (D31)(MIC=6.25μmol/L);Serratia marcescens (ATCC 4112)(MIC=3.12μmol/L);Enterobacter cloacae (beta-12)(MIC=50μmol/L);Gram-positive bacteria:Micrococcus luteus (A270)(MIC=3.12μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=12.5μmol/L);Bacillus subtilis (ATCC 6633)(MIC=12.5μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=6.25μmol/L);Fungi:Candida albicans MDM8(MIC=6.25μmol/L);Candida tropicalis (IOC 4560)(MIC=12.5μmol/L);Cryptococcus neoformans(MIC=6.25μmol/L)", "Hemolytic Activity": "[Ref.27912176] MHC=1.60μmol/L against human red blood cells", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "The peptide adopts Helical fraction 0.01 in water;0.11 in TFE/Water;0.24 in POPC;0.14 in POPC:POPG;0.23 in POPC:DOPE;", "Formula": "C82H113N17O18", "Mass": 1624.88, "PI": 6.0, "Net Charge": 0, "Hydrophobicity": 0.59, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It analog displayed a reduction in the antimicrobial activity, being the exceptions Escherichia coli SBS 363, Bacillus subtilis and Candida albicans.", "Literature": [{"Title": "Novel designed VmCT1 analogs with increased antimicrobial activity.", "Pubmed ID": "27912176", "Reference": "Eur J Med Chem. 2017 Jan 27;126456-463.", "Author": "Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27912176"}, {"Title": "novel designed VmCT1 analogs with increased antimicrobial activity", "Pubmed ID": "", "Author": "Pedron Cn, Torres MT, Lima JA, Silva PI, Silva FD, Oliveira VX"}], "Frequent Amino Acids": "FLV", "Absent Amino Acids": "ACDHIMOPQRTUY", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 5, "Positive Residues": 1, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11713", "Similarity": 0.9230769230769231, "Sequence": "FLGELWNVAKSVF"}, {"SPADE_ID": "SPADE_UN_11715", "Similarity": 0.9230769230769231, "Sequence": "FLGALWNVWKSVF"}, {"SPADE_ID": "SPADE_N_03252", "Similarity": 0.8461538461538461, "Sequence": "FLGALWNVAKSVF"}]}}}